DisGeNET

DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.

Source Last Updated
DisGeNET July 29, 2024
Displaying entries 3976 - 4000 of 62743 in total
Disease ID Disease Name Gene Symbol ▼ Gene ID Gene Name UniProt ID
C0010068 Coronary heart disease ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C1306459 Primary malignant neoplasm ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0017638 Glioma ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0007847 Malignant tumor of cervix ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0206708 Cervical Intraepithelial Neoplasia ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0302592 Cervix carcinoma ST6GALNAC5 81849 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 5 Q9BVH7
C0027651 Neoplasms ST6GALNAC4 27090 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 Q9H4F1
C0206682 Follicular thyroid carcinoma ST6GALNAC4 27090 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 Q9H4F1
C0018378 Guillain-Barre Syndrome ST6GALNAC4 27090 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 4 Q9H4F1
C0600139 Prostate carcinoma ST6GALNAC3 256435 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 Q8NDV1
C0085207 Gestational Diabetes ST6GALNAC3 256435 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 Q8NDV1
C1837461 SCOLIOSIS, ISOLATED, SUSCEPTIBILITY TO, 3 ST6GALNAC3 256435 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 Q8NDV1
C0376358 Malignant neoplasm of prostate ST6GALNAC3 256435 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 Q8NDV1
C0011860 Diabetes Mellitus, Non-Insulin-Dependent ST6GALNAC3 256435 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 3 Q8NDV1
C0025202 melanoma ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0006826 Malignant Neoplasms ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C1458155 Mammary Neoplasms ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0027651 Neoplasms ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0017661 IGA Glomerulonephritis ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0009402 Colorectal Carcinoma ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0006142 Malignant neoplasm of breast ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0678222 Breast Carcinoma ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C0206682 Follicular thyroid carcinoma ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C1269683 Major Depressive Disorder ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37
C1306459 Primary malignant neoplasm ST6GALNAC2 10610 ST6 N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 Q9UJ37

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024